Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ · Manufacturing · Pharmaceutical preparations
MDGL price, last 12 months
Key stats
- Previous close
- $398.08
- Open
- $400.00
- Day range
- $393.67 – $411.13
- 52-week range
- $353.54 – $615.00
- Volume
- 416.6K
- Avg volume (20 days)
- 617.1K
- Market cap
- $9.9B
Performance
Technicals and fundamentals
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $9.9B